Xstrahl

10/02/2026

We developed Radiant AURA to deliver both electronic brachytherapy and superficial radiation therapy in order to give dermatologists multiple treatment options for their NMSC patients.

LEARN MORE: https://xstrahl.com/radiation-therapy-is-more-accessible-than-you-think/

09/29/2026

09/27/2026

Rain outside, full house inside!

Day 1 at ASTRO 2026 at the Xstrahl booth is all about high energy conversations on low-dose radiation therapy.

There’s still time to come see us!

09/25/2026

We're heading to Boston! Come See Us at ASTRO 2026 Booth 1936.

If you're on-site this weekend, stop by the Xstrahl booth to Learn how you can increase your capacity to treat benign conditions by combining the capability of orthovoltage X-ray systems with the traditional ease-of-use of superficial radiation therapy

Plus, catch two live Q&A sessions with leading voices in the field:

🔹Dr. Bobby Koneru, MD, FASTRO: Behind the Study session, live Q&A following his presentation on the randomized controlled trial on LDRT for knee osteoarthritis, on Sunday, Sept 27 (2:45–5:00 PM)

🔹Prof. Michael Heinrich Seegenschmiedt: A Conversation on 30 Years of Redefining Radiation Medicine on Saturday and Sunday (12:00–1:30 PM) to discuss his 30+ years experience pioneering LDRT for benign conditions.

See you there!

09/15/2026

🎬 We are ready for our close up!

Our orthovoltage technology just had its reality TV debut! On The Bad Skin Clinic (Discovery+, S8:E3), Dr. Emma Craythorne turned to an Xstrahl system to treat a patient battling severe facial keloid scarring, giving her a non-surgical path forward after years of searching for answers.

Curious how it works? We've broken down the science behind radiotherapy for keloid scarring, who's a candidate, what the treatment course looks like, and the outcomes clinicians are seeing in an on-demand webinar you can watch anytime.

WATCH NOW: https://xstrahl.com/srt-dicks/

09/07/2026

🎉 Xstrahl turns 30 and we are celebrating 30 years of redefining radiation medicine.

It's not a coincidence we're announcing it today, as September 7 is World Radiotherapy Awareness Day, a day the global radiation oncology community comes together under one voice to highlight radiotherapy as a safe, essential, cost-effective cancer treatment that cures, relieves symptoms, and improves quality of life.

Our story goes back even further than 30 years. Therapeutic X-rays have been used to treat disease since 1896. The foundation of radiation therapy, kilovoltage X-ray technology, is still to this day, one of the most widely used tools in cancer care. Xstrahl has spent three decades building on that foundation.

We're also honoring where it all started, with our founder, Martin Robinson, whose family has chosen to reinvest in Xstrahl, a vote of confidence in the mission he built and in the impact this technology continues to have on cancer research, treatment, and pain relief for patients around the world.

Read the full news release here:
https://xstrahl.com/xstrahl-marks-30-years-of-advancing-radiation-therapy-on-world-radiotherapy-awareness-day/

08/25/2026

Radiation for osteoarthritis pain.
For most patients, the first reaction is fear, not relief.

A new retrospective analysis in International Journal of Radiation Oncology, Biology, Physics, followed 4,699 patients treated with orthovoltage radiotherapy for up to 20 years, making it the largest and longest-tracked LDRT safety cohort published to date. And it gives clinicians something more useful than reassurance: an actual answer.

The findings are more nuanced than “safe” or “risky,” and that nuance is exactly what makes this useful in the exam room. Peripheral joints showed no meaningful cancer signal. Marrow-rich and central trunk sites warrant more careful case selection.

At Xstrahl, orthovoltage sits at the center of functional radiotherapy for MSK conditions. We’re proud to support the evidence behind it and to see data like this reach the clinicians who need it.

Follow the link in the bio to read the full publication.

08/19/2026

We’re excited to announce that Xstrahl will be at ESTRO Meets Asia: FARO-ESTRO Congress 2026 in Singapore, August 28–30, 2026!

Stop by our booth to see how orthovoltage therapy is redefining radiation medicine. Come learn how our Orthovoltage XRT systems expand your capacity to treat pain & benign conditions like keloid scarring, Ledderhose disease, Dupuytren’s disease, and osteoarthritis, combining the power of orthovoltage X-ray with the simplicity of superficial radiation therapy, and serving as a low-cost, high-value complement to your linear accelerator.

We’ll also be running live demonstrations of XBeam, our FDA 510(k)-cleared dose planning software that automates planning, reduces risk, and integrates seamlessly with Concerto, our clinical interface built for intuitive workflows and detailed patient records.

If you’re headed to ESTRO Meets Asia 2026, come see what’s possible with orthovoltage. We can’t wait to see you there!

08/19/2026

We’re excited to announce that Xstrahl will be at ESTRO Meets Asia: FARO-ESTRO Congress 2026 in Singapore, August 28–30, 2026!

Stop by our booth to see how orthovoltage therapy is redefining radiation medicine. Come learn how our Orthovoltage XRT systems expand your capacity to treat pain & benign conditions like keloid scarring, Ledderhose disease, Dupuytren’s disease, and osteoarthritis, combining the power of orthovoltage X-ray with the simplicity of superficial radiation therapy, and serving as a low-cost, high-value complement to your linear accelerator.

We’ll also be running live demonstrations of XBeam, our FDA 510(k)-cleared dose planning software that automates planning, reduces risk, and integrates seamlessly with Concerto, our clinical interface built for intuitive workflows and detailed patient records.

If you’re headed to ESTRO Meets Asia 2026, come see what’s possible with orthovoltage. We can’t wait to see you there!

Singapore

07/02/2026

New Live Webinar Announcement! 📣 Introducing the SARRP Education Series: Expert Training from Penn Medicine & Xstrahl

Join us on July 30th for a LIVE WEBINAR and Q&A SESSION to explore our newest SARRP Education Series, in partnership with OncoLink, and get a behind-the-scenes look at Penn Medicine's SARRP research facility.

In this webinar, you'll get:
- An introduction to the SARRP Education Series
- A sneak peek at a brand-new online learning platform
- An inside look at how Penn Medicine integrates SARRP into their research workflow
- Practical insights and best practices from real-world SARRP use

📅 Thursday, July 30, 2026
🕚 11:00 AM EST / 4:00 PM BST
💬 Live Q&A Session

Whether you're a researcher, clinician, or just curious about the future of SARRP training, this is your opportunity to learn from the experts shaping the future of SARRP training.

🔗 Registration is OPEN: https://register.gotowebinar.com/register/8985603103776831062

Presented by:
Shiva Shahrampour, Ph.D., is the Technical Director of the Cell and Animal Radiation Core (CARC) at the University of Pennsylvania School of Medicine. A Medical Physicist with over 12 years of experience in medical imaging and in-vivo X-ray and MRI research, Shiva has led CARC since 2023, overseeing SARRP operations, user training, and major equipment upgrades under the CIRP program. Her work sits at the intersection of translational research and technical innovation in preclinical radiation science.

Courtney Misher, MPH, BS, R.T.(T), CTP brings 20 years of experience in radiation therapy, including a pivotal role launching Penn Medicine's Roberts Proton Therapy Center and treating its first proton patient. A longtime advocate for education in oncology, Courtney helped build Penn Medicine's Global Education Program and now serves as Strategic Partnerships Administrator at OncoLink, where she develops content and programs, including for the Penn Radiation Medicine Institute.

Special thanks to our partners at Penn Medicine Radiation Oncology and OncoLink!